Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$5.38 and last traded at C$5.31, with a volume of 55252 shares traded. The stock had previously closed at C$4.96.
Medexus Pharmaceuticals Trading Up 6.7%
The firm has a market capitalization of C$167.48 million, a PE ratio of -75.57 and a beta of 0.20. The firm has a 50 day simple moving average of C$4.65 and a 200 day simple moving average of C$3.84.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Stories
- Five stocks we like better than Medexus Pharmaceuticals
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
